Meyers, K., Cogan, D. A., Burke, J., Arenas, R., Balestra, M., Brown, N. F., Chen, Z., Cerny, M. A., Clifford, H. E., Colombo, F., Fader, L., Frederick, K. S., Guo, X., Goldberg, D., Hornberger, K. R., Kugler, S., Lord, J., Marshall, D. R., Moss, N., Parmentier, J., Richman, J. R., Schmenk, J., Weldon, S. M., Yu, M., & Zhang, M. (2018). dihydrobenzisoxazole-4-one compounds are novel selective inhibitors of aldosterone synthase (CYP11B2) with in vivo activity. Bioorganic & medicinal chemistry letters, 28(5), 979–984. http://access.bl.uk/ark:/81055/vdc_100057225405.0x00001e